HEMATOLOGIC DISORDER

Clinical trials for HEMATOLOGIC DISORDER explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC DISORDER trials appear

Sign up with your email to follow new studies for HEMATOLOGIC DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug aims to fix dangerous blood problems caused by cancer immunotherapy

Disease control Not yet recruiting

This study tests a drug called golidocitinib in 16 people with advanced lung cancer who have severe, hard-to-treat blood problems caused by immunotherapy. The goal is to see if the drug can safely reverse these blood side effects. Participants must not have had cancer growth in t…

Matched conditions: HEMATOLOGIC DISORDER

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control

Last updated May 17, 2026 06:52 UTC

HEMATOLOGIC DISORDER

Get alerted when new HEMATOLOGIC DISORDER trials appear

New drug aims to fix dangerous blood problems caused by cancer immunotherapy